[HTML][HTML] Immune-checkpoint inhibitors: long-term implications of toxicity
The development of immune-checkpoint inhibitors (ICIs) has heralded a new era in cancer
treatment, enabling the possibility of long-term survival in patients with metastatic disease …
treatment, enabling the possibility of long-term survival in patients with metastatic disease …
[PDF][PDF] Immune-checkpoint inhibitors: long-term implications of toxicity
DB Johnson, CA Nebhan, JJ Moslehi, JM Balko - apef.com.pt
The development of immune-checkpoint inhibitors (ICIs) has heralded a new era in cancer
treatment, enabling the possibility of long-term survival in patients with metastatic disease …
treatment, enabling the possibility of long-term survival in patients with metastatic disease …
[HTML][HTML] Immune-checkpoint inhibitors: long-term implications of toxicity
DB Johnson, CA Nebhan, JJ Moslehi… - Nature Reviews …, 2022 - ncbi.nlm.nih.gov
The development of immune-checkpoint inhibitors (ICIs) has heralded a new era in cancer
treatment, enabling the possibility of long-term survival in patients with metastatic disease …
treatment, enabling the possibility of long-term survival in patients with metastatic disease …
[引用][C] Immune-checkpoint inhibitors: long-term implications of toxicity
DB Johnson, CA Nebhan, JJ Moslehi… - Nature Reviews Clinical …, 2022 - cir.nii.ac.jp
Immune-checkpoint inhibitors: long-term implications of toxicity | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
Immune-checkpoint inhibitors: long-term implications of toxicity.
DB Johnson, CA Nebhan, JJ Moslehi… - Nature reviews. Clinical …, 2022 - europepmc.org
The development of immune-checkpoint inhibitors (ICIs) has heralded a new era in cancer
treatment, enabling the possibility of long-term survival in patients with metastatic disease …
treatment, enabling the possibility of long-term survival in patients with metastatic disease …
Immune-checkpoint inhibitors: long-term implications of toxicity
DB Johnson, CA Nebhan… - Nature reviews …, 2022 - pubmed.ncbi.nlm.nih.gov
The development of immune-checkpoint inhibitors (ICIs) has heralded a new era in cancer
treatment, enabling the possibility of long-term survival in patients with metastatic disease …
treatment, enabling the possibility of long-term survival in patients with metastatic disease …